Contineum Therapeutics, Inc. (CTNM) Total liabilities 2023–2024
Contineum Therapeutics, Inc. (CTNM) total liabilities at each fiscal year-end, per SEC filings.
$14.8MFY2024 · since FY2023: $5.7M → $14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $14.8M | +159.2% |
| FY2023 | $5.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice